These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6363320)

  • 41. [Expression CD27 on T and B lymphocytes in hypertrophied adenoids at children with otitis media with effusion].
    Ratomski K; Zelazowska-Rutkowska B; Wysocka J; Skotnicka B; Kasprzycka E; Hassmann-Poznańska E
    Otolaryngol Pol; 2009; 63(3):264-70. PubMed ID: 19886534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
    Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
    Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children.
    Hotomi M; Yamanaka N; Saito T; Shimada J; Suzumoto M; Suetake M; Faden H
    Acta Otolaryngol; 1999; 119(6):703-7. PubMed ID: 10587005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New vaccines for the prevention of pneumococcal infections.
    Käyhty H; Eskola J
    Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media.
    Soininen A; Lahdenkari M; Kilpi T; Mäkelä PH; Käyhty H
    Pediatr Infect Dis J; 2002 Mar; 21(3):186-92. PubMed ID: 12005079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison otitis media due to types 3 and 23 Streptococcus pneumoniae in the Chinchilla model.
    Giebink GS; Quie PG
    J Infect Dis; 1977 Aug; 136 Suppl():S191-5. PubMed ID: 19539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capsular switching as a strategy to increase pneumococcal virulence in experimental otitis media model.
    Sabharwal V; Stevenson A; Figueira M; Orthopoulos G; Trzciński K; Pelton SI
    Microbes Infect; 2014 Apr; 16(4):292-9. PubMed ID: 24361902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological and bacteriological studies on mucosa-associated lymphatic tissue in children with SOM.
    Rynnel-Dagöö B; Forsgren J; Samuelson A
    Adv Otorhinolaryngol; 1992; 47():120-3. PubMed ID: 1456119
    [No Abstract]   [Full Text] [Related]  

  • 50. [The relationship between adenoids hypertrophy and secretory otitis media].
    Yin G; Yue Z; Hu J; Zhao X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(13):588-9. PubMed ID: 16200826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ analysis of the immune microenvironment of the adenoid in children with and without secretory otitis media.
    Forsgren J; Rynnel-Dagöö B; Christensson B
    Ann Otol Rhinol Laryngol; 1995 Mar; 104(3):189-96. PubMed ID: 7872601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of percentage of lymphocytes B with expression of co-receptors CD 40, CD22 and CD72 in hypertrophied adenoid at children with otitis media with effusion].
    Wysocka J; Zelazowska-Rutkowska B; Ratomski K; Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 2009; 63(6):504-8. PubMed ID: 20198985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
    Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
    J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
    Sloyer JL; Ploussard JH; Howie VM
    Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secretory otitis media: microbiology of the middle ear and the nasopharynx.
    Kamme C; Nilsson NI
    Scand J Infect Dis; 1984; 16(3):291-6. PubMed ID: 6387891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of percentage of the CD19+CD5+ lymphocytes in hypertrophied adenoids at children with otitis media with effusion].
    Ratomski K; Skotnicka B; Kasprzycka E; Zelazowska-Rutkowska B; Wysocka J; Anisimowicz S
    Otolaryngol Pol; 2007; 61(6):962-6. PubMed ID: 18546943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dendritic cells in hypertrophied adenoid at children with otitis media with effusion].
    Zelazowska-Rutkowska B; Ratomski K; Wysocka J; Kasprzycka E; Hassmann-Poznańska E; Mrugacz M
    Otolaryngol Pol; 2009; 63(4):348-52. PubMed ID: 19999753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
    Eskola J
    Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocyte subpopulations in hypertrophied adenoid in children with otitis media with effusion.
    Wysocka J; Hassmann E; Kasprzycka E; Musiatowicz M; Lipska A
    Rocz Akad Med Bialymst; 2002; 47():105-12. PubMed ID: 12533952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.